Virtual Medicinal Product (VMP) - Generic Triumeq 5mg/60mg/30mg dispersible tablets sugar free
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Generic Triumeq 5mg/60mg/30mg dispersible tablets sugar free | Start Date 18-12-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Dispersible tablet
- Ontology Form/Route
- suspension.oral
- Free From
- Sugar-free
- Name Basis
- Other
Codes
- ATC Code
- J05AR13
- BNF Codes
-
- BNF code 05030100
| Code | Start Date | End Date |
|---|---|---|
| 42534411000001107 | 18-12-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Abacavir sulfate | Based on Base Substance | Abacavir | 60 mg | |
| Dolutegravir sodium | Based on Base Substance | Dolutegravir | 5 mg | |
| Lamivudine | Based on Ingredient Substance | 30 mg |
Name
Lamivudine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30
Strength and UOM (Dmr)
Name
Abacavir sulfate
Basis of strength description
Based on Base Substance
BOSS
Abacavir
Strength and UOM (Nmr)
60
Strength and UOM (Dmr)
Name
Dolutegravir sodium
Basis of strength description
Based on Base Substance
BOSS
Dolutegravir
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Parent Products
-
VTMAbacavir + Lamivudine + Dolutegravir
-
VMP(Current) Generic Triumeq 5mg/60mg/30mg disper...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 90 tablet |